TScan Therapeutics, Inc.TCRXNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P50
Within normal range
vs 5Y Ago
-0.3x
Contraction
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | -22.10% |
| 2024 | -80.62% |
| 2023 | 7.74% |
| 2022 | -36.62% |
| 2021 | -1510.22% |
| 2020 | 75.86% |
| 2019 | 0.00% |